Published

Long-term effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 model of OCD-like behavior

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: Neuroscience Applied
Date: 2024-12-31
Source: OpenAlex
DOI: 10.1016/j.nsa.2025.105450
PubMed: Unavailable

Authors

Michal Brownstien

Watch author

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Long-term effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 model of OCD-like behavior2024-12-31

Related papers

Examining Attitudes to Psilocybin: Should Candidates for Medical Psilocybin be Required to Pass a Contextual Suitability Test?Journal of Humanistic Psychology · 2022-08-17 Expectancies for Subjective and Antidepressant Effects in Psilocybin UsersJournal of Humanistic Psychology · 2023-09-21 Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of AlcoholismJournal of Humanistic Psychology · 2016-10-15 Skinner, Maslow, and PsilocybinJournal of Humanistic Psychology · 1993-06-30 The phenomenology of psilocybin: transformative insights for research and clinical practiceFrontiers in Psychology · 2025-04-24 B - 61 Psilocybin as a First-Line Treatment of ADHD in Adult PopulationsArchives of Clinical Neuropsychology · 2024-09-11 Production of Cross-Tolerance to Psychosis-Producing Doses of Lysergic Acid Diethylamide and PsilocybinThe Journal of Psychology · 1959-12-31 Salience, sensemaking, and setting in psilocybin microdosing: Methodological lessons and preliminary findings of a mixed method qualitative studyPhilosophical Psychology · 2024-09-25